| abstract |
The invention relates to the use of at least one active ingredient for the prophylaxis and/or therapy of a viral disease, whereby said active ingredient inhibits at least one component of the cellular transmission pathway for activation of the transcription factor NF-kB, such that viral multiplication is inhibited. The invention further relates to the local, preferably air-borne administration of said active ingredients for inhibition of a viral multiplication. Said active ingredients can be combined with at least one further anti-virally effective substance for the prophylaxis and/or therapy of a viral disease. |